Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
7.22
+0.43 (6.33%)
At close: Oct 27, 2025, 4:00 PM EDT
7.30
+0.08 (1.11%)
After-hours: Oct 27, 2025, 5:19 PM EDT
Evolus Market Cap
Evolus has a market cap or net worth of $467.03 million as of October 27, 2025. Its market cap has decreased by -55.86% in one year.
Market Cap
467.03M
Enterprise Value
560.20M
1-Year Change
-55.86%
Ranking
Category
Stock Price
$7.22
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.32M to $467.03M, an increase of 72.13%. That is a compound annual growth rate of 7.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 439.21M | -37.17% |
| Dec 31, 2024 | 699.07M | 14.94% |
| Dec 29, 2023 | 608.22M | 43.99% |
| Dec 30, 2022 | 422.41M | 16.75% |
| Dec 31, 2021 | 361.81M | 219.06% |
| Dec 31, 2020 | 113.40M | -72.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |